These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 22178300)

  • 1. Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.
    van Bregt DR; Thomas TC; Hinzman JM; Cao T; Liu M; Bing G; Gerhardt GA; Pauly JR; Lifshitz J
    Exp Neurol; 2012 Mar; 234(1):8-19. PubMed ID: 22178300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat.
    Cao T; Thomas TC; Ziebell JM; Pauly JR; Lifshitz J
    Neuroscience; 2012 Dec; 225():65-75. PubMed ID: 22960311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.
    Hutson CB; Lazo CR; Mortazavi F; Giza CC; Hovda D; Chesselet MF
    J Neurotrauma; 2011 Sep; 28(9):1783-801. PubMed ID: 21644813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury.
    Liu M; Bachstetter AD; Cass WA; Lifshitz J; Bing G
    J Neurotrauma; 2017 Jan; 34(2):414-422. PubMed ID: 27142118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
    Zaman V; Nelson ME; Gerhardt GA; Rohrer B
    Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
    Bezard E; Jaber M; Gonon F; Boireau A; Bloch B; Gross CE
    Eur J Neurosci; 2000 Aug; 12(8):2892-900. PubMed ID: 10971632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.
    Kramer BC; Mytilineou C
    J Neurocytol; 2004 Mar; 33(2):213-23. PubMed ID: 15322379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
    Salvatore MF
    J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
    Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
    Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.
    Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW
    J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
    Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
    Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology in sensory, but not motor, brainstem nuclei of the rat whisker circuit after diffuse brain injury.
    Miremami JD; Talauliker PM; Harrison JL; Lifshitz J
    Somatosens Mot Res; 2014 Sep; 31(3):127-35. PubMed ID: 24702476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.
    Healy-Stoffel M; Ahmad SO; Stanford JA; Levant B
    J Neurosci Methods; 2012 Sep; 210(2):187-94. PubMed ID: 22850559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.